Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer

Medicine and Dentistry

• Lung Cancer 100%
• Oncogene 100%
• Clinical Trial 33%
• Diagnosis 33%
• Patient Population 33%
• Exon 33%
• Epidermal Growth Factor Receptor 33%
• Molecular Epidemiology 33%
• Targeted Therapy 33%
• Next Generation Sequencing 33%

Keyphrases

• Skipping mutations 33%
• Fusion mutation 33%
• Oncogenic Driver Alterations 33%
• NTRK Fusion 33%
• MET Exon 14 33%
• EGFR Exon 20 Insertion 33%
• KRAS G12C mutation 33%